Koyfin Home > Directory > Health Care > Akebia Therapeutics > Cost of Goods Sold

Akebia Therapeutics Cost of Goods Sold Chart (AKBA)

Akebia Therapeutics annual/quarterly Cost of Goods Sold from 2015 to 2020.
  • Akebia Therapeutics Cost of Goods Sold for the quarter ending June 06, 2020 was $74m a -13.03% decrease of -10m year over year
  • Akebia Therapeutics Cost of Goods Sold for the last 12 months ending June 06, 2020 was $288m a -23.69% decrease of -68m year over year
  • Akebia Therapeutics Annual Cost of Goods Sold for 2019 was $308m a 5.16% increase of 16m from 2018
  • Akebia Therapeutics Annual Cost of Goods Sold for 2018 was $293m a 21.08% increase of 62m from 2017
  • Akebia Therapeutics Annual Cost of Goods Sold for 2017 was $231m a 49.85% increase of 115m from 2016
Other Income Statement Metrics:
  • Akebia Therapeutics EBITDA for the quarter ending December 12, 2018 was $-85m a 71.45% decrease of -61m year over year
  • Akebia Therapeutics Net Income for the quarter ending December 12, 2018 was $-88m a 73.50% decrease of -65m year over year
  • Akebia Therapeutics Total Revenue for the quarter ending December 12, 2018 was $60m a 23.26% increase of 14m year over year
View Chart On Koyfin

Quarterly AKBA Cost of Goods Sold Data

06/2020$74m
03/2020$89m
12/2019$41m
09/2019$84m
06/2019$95m
03/2019$91m
12/2018$89m
09/2018$71m
06/2018$72m
03/2018$61m

Annual AKBA Cost of Goods Sold Data

2019$308m
2018$293m
2017$231m
2016$116m
2015$43m
2014$23m